New research from Duke University, published in the March 2019 issue of JNCCN—Journal of the National Comprehensive Cancer Network, provides evidence that genomic recurrence score (RS) testing using the 21-gene assay is associated with lower costs for people with clinically high-risk breast cancer.
The National Comprehensive Cancer Network® (NCCN®) Oncology Research Program (ORP) has funded three investigators from NCCN Member Institutions through a collaborative scientific research relationship with Taiho Oncology, Inc.
More than 1,500 cancer care professionals are meeting in Orlando, Florida, March 21-23, for the NCCN 2019 Annual Conference, presented by the National Comprehensive Cancer Network® (NCCN®)—an alliance of 28 leading cancer centers.
New NCCN Guidelines for Patients: Squamous Cell Skin Cancer explains risk factors and treatment options for cancer type that impacts millions every year.
Study in JNCCN finds coronary artery disease costs increase dramatically in patients who are diagnosed with cancer.
The National Comprehensive Cancer Network® (NCCN®) announces formal endorsements from the governments of Ethiopia, Nigeria, and Tanzania for the NCCN Harmonized Guidelines™ for Sub-Saharan Africa, while joining cancer leaders across the globe to raise awareness and take action for World Cancer Day on February 4.
The National Comprehensive Cancer Network® (NCCN®) has published updated resources for improving and facilitating quality, effective, efficient, and accessible cancer care in the Middle East and North Africa (MENA).
Researchers from Yale School of Public Health find that genetic profiling for cancer tumors is cost-effective for high- and medium-risk patients with breast cancer, but is unlikely to make a meaningful impact on treatment for low-risk patients, in study published in January 2019 issue of JNCCN-Journal of the National Comprehensive Cancer Network
The National Comprehensive Cancer Network® (NCCN®) announced that the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) were downloaded more than 10 million times in 2018; marking a 26% increase over 2017.
Findings published in JNCCN-Journal of the National Comprehensive Cancer Network examine the differences between patient- and clinician-reported outcomes; recommend a greater focus on the cumulative effect of multiple low-level toxicities.
Advocates, patients, providers, and other experts examine disparities and explore solution at the NCCN Patient Advocacy Summit on Equity in Cancer Care
NCCN Oncology Research Program Awarded $2 Million from Lilly to Study Mechanisms of Resistance to CDK4 & 6 Inhibitors in Breast Cancer Treatment
The Abramson Cancer Center joins 27 other leading academic cancer centers from across the United States in creating the most frequently updated cancer care guidelines worldwide, as an NCCN Member Institution.
NCCN Guidelines for Patients®: Oral Cancers provides information about mouth cancers for patients and caregivers.
New research published in JNCCN-Journal of the National Comprehensive Cancer Network found Latino men were 21% less likely to receive definitive treatment compared to non-Latino white men, with significant differences for younger patients, the uninsured, and those treated at NCI-designated centers.
New agreement between National Comprehensive Cancer Network and Syapse will augment health information technology around precision medicine and biomarkers in cancer care
The National Comprehensive Cancer Network’s Oncology Research Program received a grant to investigate effectiveness of trifluridine and tipiracil for treatment of people with colorectal, gastric, and other cancers
NCCN publishes updated patient and clinical guidelines for breast cancer in conjunction with free webinars. New NCCN Harmonized Guidelines for the Caribbean released for breast cancer and other types. Global Summit on International Breast Health and Cancer Control begins.
New NCCN Guidelines for Patients: NET provides background and treatment information for neuroendocrine tumors, the type of cancer experienced by Aretha Franklin and Steve Jobs
National Comprehensive Cancer Network (NCCN) moves into new global headquarters in Plymouth Meeting, PA, in the Greater Philadelphia area, less than three hour's drive from Washington, D.C., New York City, and Princeton, NJ.
Researchers from Netherlands Cancer Institute recommend qualitative and quantitative measurements that can lead to more successfully coordinated cancer care, finds need for better organization around the integration of care, according to article in September 2018 issue of JNCCN-Journal of the Comprehensive Cancer Network.
National Comprehensive Cancer Network convenes Policy Summit to address changing care paradigms, and the impact across the cancer care continuum
NCCN Oncology Research Program puts out request for proposals (RFP) for innovative strategies to improve patient outcomes for people with gastric and gastroesophageal junction cancer. Letters of intent due October 24.
National Comprehensive Cancer Network publishes NCCN Guidelines for Patients: Uterine Cancer during Gynecologic Cancer Awareness Month to explain treatment options and raises awareness of endometrial cancer, the most common type of gynecologic cancer.
Study from the American Cancer Society, published in JNCCN--Journal of the National Comprehensive Cancer Network, found cancer patients who were more satisfied with the communication they received, had better health results at lower costs
New NCCN Guidelines for gestational trophoblastic neoplasia created to ensure pregnant women with cancer receive life-saving treatment while preserving fertility
JNCCN—Journal of the National Comprehensive Cancer Network introduces new Executive Editorial Board, reaches new heights for readership and impact rating thanks to expanding content, including new studies, panel insights, and NCCN Guidelines®
New Study in JNCCN focuses on women under 40 with breast cancer finds that young women who are treated with chemotherapy for breast cancer but have residual tumor in either the breast or lymph nodes have higher chances of recurrence compared to those with no evidence of any residual invasive tumor (pathologic complete response).
NCCN convenes summit on providing high-quality cancer care in an evolving policy and tech landscape, featuring FDA Chairman Scott Gottlieb, Co-Chairs of the Congressional Survivors Caucus, Congressmen Mark DeSaulnier and Ted Poe, and new data on the impact of narrow networks on cancer care delivery.
In new study in JNCCN - Journal of the National Comprehensive Cancer Network, Netherlands-based researchers found emergency colon cancer surgery was more likely to lead to complications if performed on a weekend, rather than a weekday.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right